SB225002 No Further a Mystery
Inhibition of EZH2 methyltransferase action might stand for a feasible method to the therapy of cancers with superior EZH2 action. The development of EZH2-particular inhibitors has been an Lively location of investigation (9, eleven, 32). Without a doubt, GSK126 is one of many applicant compounds which might be presently being evaluated in preclini